Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Akira Mima"'
Publikováno v:
Metabolism Open, Vol 22, Iss , Pp 100294- (2024)
Introduction: Diabetic kidney disease (DKD) is an important complication of diabetes as it results in end-stage renal disease; hence, several drugs have been developed for its treatment. However, even with treatment with renin-angiotensin system inhi
Externí odkaz:
https://doaj.org/article/b25a40852a8a4632a0720e766f126495
Autor:
Akira Mima, Yasuhiro Horii
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 7, Iss 3, Pp n/a-n/a (2024)
ABSTRACT Objective Tirzepatide is an injectable peptide approved by the US Food and Drug Administration for the treatment of Type 2 diabetes (T2DM). Its weight‐loss effect primarily targets fat reduction; however, such effect on patients with chron
Externí odkaz:
https://doaj.org/article/670fbb084af44f7abaaf7adddf359374
Publikováno v:
F1000Research, Vol 12 (2023)
Immunoglobulin G4 (IgG4)-related disease is a systemic inflammatory disorder characterized by tubulointerstitial nephritis with IgG4-positive plasma cell infiltration. We report the case of an 84-year-old male who presented with a history of dyspnea
Externí odkaz:
https://doaj.org/article/c6f76165e2a147a9b39f2cdec4185593
Autor:
Akira Mima, Rina Lee, Ami Murakami, Hidemasa Gotoda, Ryosuke Akai, Sayumi Kidooka, Takahiro Nakamoto, Suguru Kido, Shinji Lee
Publikováno v:
Metabolism Open, Vol 19, Iss , Pp 100251- (2023)
Background: In the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease trial, finerenone reduced the risk of cardiovascular events in patients with chronic kidney disease (CKD) and type 2 diabetes, while in the Fi
Externí odkaz:
https://doaj.org/article/13b25c1a51cb4665832d3bfd1de85229
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 165, Iss , Pp 115032- (2023)
Diabetic kidney disease (DKD) is the most common cause of chronic kidney disease (CKD), leading end-stage renal disease. Thus, DKD is one of the most important diabetic complications. Incretin-based therapeutic agents, such as glucagon-like peptide-1
Externí odkaz:
https://doaj.org/article/c781c0d7681a4698a5081bb59bdaa276
Publikováno v:
F1000Research, Vol 12 (2023)
Immunoglobulin G4 (IgG4)-related disease is a systemic inflammatory disorder characterized by tubulointerstitial nephritis with IgG4-positive plasma cell infiltration. We report the case of an 84-year-old male who presented with a history of dyspnea
Externí odkaz:
https://doaj.org/article/0f5cda1a5554411a830b8b7e6883a78d
Autor:
Akira Mima
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Non-alcoholic fatty liver disease is the most common chronic liver disease and is associated with chronic kidney disease. The fibrosis-4 index and non-alcoholic fatty liver disease score are widely used as non-invasive diagnostic methods for
Externí odkaz:
https://doaj.org/article/ec88aec37b1849a5918e3446d5b23ee3
Autor:
Akira Mima, Shinji Lee
Publikováno v:
Heliyon, Vol 9, Iss 6, Pp e17206- (2023)
Background: Immunoglobin A nephropathy (IgAN) is one of the most common forms of chronic glomerulonephritis and has been shown to occur in association with vaccinations. While various vaccines against COVID-19 have become widely used, their side effe
Externí odkaz:
https://doaj.org/article/5ad4c77424714f138bfb72faa0822274
Publikováno v:
Metabolism Open, Vol 18, Iss , Pp 100240- (2023)
Background: In rodents, glomerular expression of insulin receptor substrate 1 (IRS1) is decreased in diabetic kidney disease (DKD) and reduced associated functioning is involved in the development and progression of DKD. This study aimed to evaluate
Externí odkaz:
https://doaj.org/article/c08e640378b24c1c9d75566a74365e49
Publikováno v:
Metabolism Open, Vol 17, Iss , Pp 100236- (2023)
Background: This meta-analysis was conducted to investigate the effects of incretin-based therapeutic agents, including the latest agent tirzepatide, on renal outcomes in patients with type 2 diabetes. Methods: MEDLINE (via PubMed) and Cochrane datab
Externí odkaz:
https://doaj.org/article/8790ea2497e64a229b660aab8d89d47c